Market Cap 10.37B
Revenue (ttm) 221.90M
Net Income (ttm) -535.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -241.44%
Debt to Equity Ratio -1.04
Volume 1,497,500
Avg Vol 2,116,380
Day's Range N/A - N/A
Shares Out 191.17M
Stochastic %K 32%
Beta 1.36
Analysts Strong Sell
Price Target $65.80

Company Profile

BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers. The company offers Attruby, a next-generation oral small molecule near-complete TTR stabilizer for the treatment of cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM); low-dose infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor, which is in Phase 3 doub...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 391 9740
Address:
3160 Porter Drive, Suite 250, Palo Alto, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 11:04 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BBIO Current Share Price: $54.26 Contracts: $BBIO January 15, 2027 $55 Calls Scale in: $12.87- $15.73 Scale out: $20.02-$25.74 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MakeM0ney_444
MakeM0ney_444 Oct. 25 at 4:45 PM
$BBIO if great results where could this go? I only have 15 shares :-/
0 · Reply
Jblack500
Jblack500 Oct. 25 at 6:10 AM
$BBIO action packed week upcoming
0 · Reply
cubie
cubie Oct. 25 at 12:10 AM
$BBIO cubie teaches 😅
0 · Reply
justiceforb_85
justiceforb_85 Oct. 25 at 12:00 AM
$BBIO hopefully we receive a positive update on P3 for Limb-girdle Muscular Dystrophy Type 2I/R9 on Monday. Mechanism of action is sound and P2 data was decent. This would be enormous for patients.
0 · Reply
RonIsWrong
RonIsWrong Oct. 24 at 10:55 PM
$BBIO BridgeBio to Report Phase 3 Results for Small Molecule BBP-418 in LGMD2I/R9 FORTIFY Study, along with Third Quarter 2025 Financial Results Next Week
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 10:41 PM
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Oct. 24 at 9:55 PM
$BBIO protective hedging most likely. This doesn't usually move too much even after good news. Adding possible new drug to portfolio and stopping the cash burn rate for P3 is very bullish imo. 🔥🔥🔥
1 · Reply
Jusar
Jusar Oct. 24 at 9:41 PM
$BBIO not a good view from calls & puts perspective for the bulls. We shall see on Monday.
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Oct. 24 at 8:38 PM
$BBIO Monday 8 am news drop.... almost certainly bullish! 🔥🔥🔥🚀🚀🚀
0 · Reply
Latest News on BBIO
BridgeBio to Participate in September Investor Conferences

Aug 27, 2025, 7:30 AM EDT - 2 months ago

BridgeBio to Participate in September Investor Conferences


BridgeBio Pharma, Inc. (BBIO) Q2 2025 Earnings Call Transcript

Aug 9, 2025, 4:30 AM EDT - 2 months ago

BridgeBio Pharma, Inc. (BBIO) Q2 2025 Earnings Call Transcript


BridgeBio: New Data Bolsters The Bull Case

Jun 4, 2025, 3:34 AM EDT - 5 months ago

BridgeBio: New Data Bolsters The Bull Case


BridgeBio Pharma, Inc. (BBIO) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 9:43 PM EDT - 6 months ago

BridgeBio Pharma, Inc. (BBIO) Q1 2025 Earnings Call Transcript


BridgeBio: Early Signs Point To Blockbuster Revenues

Apr 22, 2025, 11:14 AM EDT - 6 months ago

BridgeBio: Early Signs Point To Blockbuster Revenues


BridgeBio Announces CFO Succession

Mar 17, 2025, 4:01 PM EDT - 7 months ago

BridgeBio Announces CFO Succession


BridgeBio: Strong Start For Attruby

Feb 20, 2025, 1:34 PM EST - 8 months ago

BridgeBio: Strong Start For Attruby


Top 4 Health Care Stocks You May Want To Dump In Q1

Jan 21, 2025, 6:06 AM EST - 9 months ago

Top 4 Health Care Stocks You May Want To Dump In Q1

BSX ISRG ITCI


BridgeBio Pharma Is A Buy On Dips After Attruby's FDA Approval

Jan 15, 2025, 9:30 AM EST - 10 months ago

BridgeBio Pharma Is A Buy On Dips After Attruby's FDA Approval


LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 11:04 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BBIO Current Share Price: $54.26 Contracts: $BBIO January 15, 2027 $55 Calls Scale in: $12.87- $15.73 Scale out: $20.02-$25.74 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MakeM0ney_444
MakeM0ney_444 Oct. 25 at 4:45 PM
$BBIO if great results where could this go? I only have 15 shares :-/
0 · Reply
Jblack500
Jblack500 Oct. 25 at 6:10 AM
$BBIO action packed week upcoming
0 · Reply
cubie
cubie Oct. 25 at 12:10 AM
$BBIO cubie teaches 😅
0 · Reply
justiceforb_85
justiceforb_85 Oct. 25 at 12:00 AM
$BBIO hopefully we receive a positive update on P3 for Limb-girdle Muscular Dystrophy Type 2I/R9 on Monday. Mechanism of action is sound and P2 data was decent. This would be enormous for patients.
0 · Reply
RonIsWrong
RonIsWrong Oct. 24 at 10:55 PM
$BBIO BridgeBio to Report Phase 3 Results for Small Molecule BBP-418 in LGMD2I/R9 FORTIFY Study, along with Third Quarter 2025 Financial Results Next Week
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 10:41 PM
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Oct. 24 at 9:55 PM
$BBIO protective hedging most likely. This doesn't usually move too much even after good news. Adding possible new drug to portfolio and stopping the cash burn rate for P3 is very bullish imo. 🔥🔥🔥
1 · Reply
Jusar
Jusar Oct. 24 at 9:41 PM
$BBIO not a good view from calls & puts perspective for the bulls. We shall see on Monday.
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Oct. 24 at 8:38 PM
$BBIO Monday 8 am news drop.... almost certainly bullish! 🔥🔥🔥🚀🚀🚀
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 8:30 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BBIO Current Share Price: $53.77 Contracts: $BBIO January 15, 2027 $55 Calls Scale in: $12.53- $15.32 Scale out: $19.50-$25.07 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 23 at 5:28 PM
$BBIO Current Stock Price: $53.35 Contracts to trade: $55 BBIO Nov 21 2025 Call Entry: $3.40 Exit: $5.87 ROI: 73% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 23 at 11:19 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BBIO Current Share Price: $53.24 Contracts: $BBIO January 15, 2027 $55 Calls Scale in: $12.60- $15.40 Scale out: $19.60-$25.20 Can Easily Capture: 60% ROI Blended DTE: 450 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
IDrinkandKnowThings
IDrinkandKnowThings Oct. 23 at 3:40 AM
$BBIO Aurinia Pharmaceuticals: Lupkynis Growth And AUR200 Pipeline Justify Buy Rating 5 Save Comments Aurinia Pharmaceuticals: Lupkynis Growth And AUR200 Pipeline Justify Buy Rating Oct. 22, 2025 11:20 PM ETAurinia Pharmaceuticals Inc. (AUPH) StockAUPH  Gamu Dave Innocent Pasi 110 Followers 5 Share Save Play(11min) Comments Summary Aurinia Pharmaceuticals is rated BUY, driven by strong Lupkynis sales growth and a robust cash position supporting pipeline development. AUPH's Lupkynis leads as the first FDA-approved oral therapy for lupus nephritis, with 22% YoY revenue growth and expanding physician adoption. The company's pipeline drug, AUR200, targets dual immune proteins and offers long-term diversification potential in a multi-billion-dollar autoimmune market. Key risks include heavy reliance on Lupkynis, patent expirations, and competitive pressures, but current financial strength supports ongoing R&D and expansion.  Moment Makers Group/iStock via Getty Images
LMXPERTEN
LMXPERTEN Oct. 22 at 2:43 PM
$BBIO soon first readout
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 5:53 PM
Raymond James has adjusted their stance on BridgeBio Pharma ( $BBIO ), setting the rating to Outperform with a target price of 56 → 59.
0 · Reply
Okadarlan
Okadarlan Oct. 21 at 3:36 PM
$BBIO i mean i made money twice on short here, 2021 and 2023 we back now again , lost once.
0 · Reply
Okadarlan
Okadarlan Oct. 21 at 3:23 PM
$BBIO New entry short , last one got burned but we will make it back + extra if it goes under 38 .
1 · Reply
knobs101
knobs101 Oct. 20 at 8:15 PM
$BBIO looks like they tried to shake a few weak hands loose this morning. Good news afoot?
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 20 at 6:45 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BBIO Current Share Price: $54.92 Contracts: $BBIO January 15, 2027 $55 Calls Scale in: $13.49- $16.49 Scale out: $20.99-$26.98 Can Easily Capture: 60% ROI Blended DTE: 453 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 17 at 9:40 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BBIO Current Share Price: $55.03 Contracts: $BBIO January 15, 2027 $60 Calls Scale in: $11.70- $14.30 Scale out: $18.20-$23.40 Can Easily Capture: 60% ROI Blended DTE: 455 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 1:11 PM
Enter: $BBIO NOV 21 2025 $60 CALLS Buy in Price: $3.68 - $4.40 Take Profit: $7.65 Stop Bleeding: $3.24 ROI Potential: 108% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply